What is Tidepool?
Tidepool is dedicated to improving diabetes management through a seamless data platform that integrates information from various medical devices. Their flagship product, Tidepool Loop, is a groundbreaking automated insulin dosing app that has received FDA clearance, marking a significant advancement in interoperable diabetes care. By empowering users with actionable insights derived from their health data, Tidepool supports both healthcare professionals and individuals managing diabetes, fostering more informed treatment decisions and enhancing overall care.
How much funding has Tidepool raised?
Tidepool has raised a total of $1.4M across 2 funding rounds:
Debt
$350K
Debt
$1M
Debt (2020): $350K with participation from PPP
Debt (2021): $1M led by PPP
What's next for Tidepool?
With its recent major strategic investment, Tidepool is poised to further expand its reach and enhance its data platform capabilities. The enterprise-level backing suggests a focus on scaling operations, broadening technological integration, and potentially developing new features to support telemedicine initiatives and advanced diabetes care. This strategic financing will likely accelerate Tidepool's mission to make diabetes data more accessible and actionable, driving further innovation in the digital health sector.
See full Tidepool company page
